𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia

✍ Scribed by Niemann, C U; Kjeldsen, L; Ralfkiaer, E; Jensen, M K; Borregaard, N

Book ID
110058485
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
275 KB
Volume
21
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Advances in Malignant Hematology Volume
Advances in Malignant Hematology Volume 1079 (Saba/Advances in Malignant Hematology) || The Molecular Biology of Acute Myeloid Leukemia
✍ Saba, Hussain I.; Mufti, Ghulam J. πŸ“‚ Article πŸ“… 2011 πŸ› Wiley-Blackwell 🌐 English βš– 534 KB

This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic and genomic changes has influenced the current outlook toward haematological malignancies. This recent

Arsenic derivatives in hematologic malig
Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
✍ Srdan Verstovsek; Francis Giles; Alfonso QuintΓ‘s-Cardama; Nichole Perez; Farhad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

The importance of arsenic trioxide (As 2 O 3 ) has been underscored over the last decade due to its efficacy against acute promyelocytic leukemia (APL), a disease in which this agent has been associated with complete hematologic and molecular remission rates of 87% and 83%, respectively. The differe